Pharmacokinetics Services Market Analysis, Size, Share, Growth, Trends, and Forecast by 2031

Pharmacokinetics Services Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type (Small Molecules, Large Molecules, and Vaccines), Service Type (Preclinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), and Geography

  • Report Code : TIPRE00007438
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 174
Buy Now

Pharmacokinetics Services Market Size, Growth, Share by 2031

Buy Now

The pharmacokinetics services market size is projected to reach US$ 874.96 million by 2031 from US$ 1,579.87 million in 2023. The market is expected to register a CAGR of 7.6% in 2023–2031. The increasing adoption of Big Data analytics is likely to remain a key pharmacokinetics services market trend.

Pharmacokinetics Services Market Analysis

Pharmacokinetic studies are being employed to determine several parameters such as human-equivalent doses (HED) level and no-observed effect level (NOEL); these studies also involve conducting pharmacokinetic/pharmacodynamic testing. The main focus of any preclinical program conducted is to support the analysis of a safe and effective dose range. Several toxicology studies provide data on the NOEL, i.e., the highest dose at which a drug exhibits no adverse effects. This dose level is further converted to an HED level on the basis of a comparative body-surface area if there is a lack of clinical pharmacokinetic data. Understanding the pharmacokinetic profile of a potential drug candidate plays an important role in the drug discovery program. Regulatory authorities play a major role in propelling the implementation of pharmacokinetic studies. These studies are also instrumental in optimizing pharmaceutical care services provided to patients admitted to hospitals. The pharmacokinetic model is often applied to determine exposure to drugs and concentrations of drugs to analyze optimal dosage and the disposition of drugs in the human body. Healthcare providers implement the principles of pharmacokinetic studies to monitor drug concentrations, determine doses of some drugs, maximize the intended therapeutic outcomes, and minimize toxicities. Thus, the expanding range of applications of pharmacokinetic studies bolsters the pharmacokinetics services market growth.

Pharmacokinetics Services Market Overview

The rising prevalence of chronic and infectious diseases, expanding application of pharmacokinetic studies, and outsourcing of pharmacokinetics services to contract research organizations boost the growth of the pharmacokinetics services market. According to the World Health Organization’s (WHO) 2024 data, ~422 million people in the world suffer from diabetes, and middle- and low-income countries account for most of these cases, causing approximately 1.5 million deaths every year. Pharmacokinetic studies are essential for understanding how drugs behave in a patient’s body by analyzing the process of absorption, distribution, metabolization, and elimination (ADME) within the human body.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Pharmacokinetics Services Market: Strategic Insights

Pharmacokinetics Services Market

  • CAGR (2023 - 2031)
    7.6%
  • Market Size 2023
    US$ 1,579.87 Million
  • Market Size 2031
    US$ 874.96 Million

Market Dynamics

GROWTH DRIVERS
  • Rising Prevalence of Chronic and Infectious Diseases Drives the Pharmacokinetics Services Market
FUTURE TRENDS
  • Expanding Range of Application of Pharmacokinetic Studies Drives the Pharmacokinetics Services Market
OPPORTUNITIES
  • Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics is the opportinity in the Pharmacokinetics Services Market

Key Players

  • Charles River Laboratories International Inc.,
  • Eurofins Scientific SE,
  • Evotec SE,
  • Certara Inc.,
  • Parexel International Corp,
  • Thermo Fisher Scientific Inc.,
  • Allucent,
  • PACIFIC BIOLABS,
  • SGS SA,
  • Shanghai Medicilon Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Drug Type
  • Small Molecules
  • Large Molecules
  • Others
Service Type
  • PK/PD Analysis and Reporting
  • Pre clinical ADME and Human Studies
  • Dosing Simulations
  • Risk Analysis
  • Others
Therapeutic Application
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Respiratory Disorders
  • Neurological Disorders
  • Gynecological
  • Others
End User
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Pharmacokinetics Services Market Drivers and Opportunities

Rising Prevalence of Chronic and Infectious Diseases Propel Market Growth

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune diseases has been a prime enabler of drug development efforts across the world. According to the World Health Organization’s (WHO) 2024 data, ~422 million in the world suffer from diabetes, and these cases are mostly found in middle and low-income countries, causing approximately 1.5 million deaths every year. Pharmaceutical companies are at the forefront of developing drugs to treat various diseases. Pharmacokinetic studies are essential for understanding how these drugs behave in a patient’s body by analyzing the process of absorption, distribution, metabolization, and elimination (ADME) within the human body. The absorption of a drug into systemic circulation affects the speed and concentration at which a drug may reach the site of action, e.g., plasma. Drug distribution pattern throughout the body varies based on its biochemical properties and body physiology. Metabolism involves the processing of the drug by the body into subsequent compounds. This step is instrumental in converting the drug into water-soluble substances to render them suitable for renal clearance. Metabolism is also important for the conversion of prodrugs, such as codeine, into active metabolites. Excretion of drugs from the body is mainly governed by kidneys; however, in several cases, drugs may be excreted via the lungs, skin, or gastrointestinal tract. ADME dynamics define the bioavailability of drugs in the body, and the maintenance doses of drugs are calculated based on their clearance times (desired plasma concentration divided by bioavailability). Understanding of clearance allows practitioners to calculate appropriate dosing rates.

Pharmacokinetic studies focus on optimizing drug dose regimens in study subjects to understand the efficacy and safety of a drug. These studies are essential for ensuring the safety of drugs that are developed for long-term treatments, which helps evaluate the suitability and stability of drug formulations in chronic disease management. Hence, the rising burden of chronic and infectious diseases underlines the importance of pharmacokinetic studies to develop safe and effective personalized treatments.

Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics to Drive Market in Coming Years

The collection and handling of huge pharmacokinetic data generated during drug manufacturing are expensive, tedious, and time-consuming tasks. The labor- and cost-intensive nature of these tasks highlights the need for models such as pharmacokinetic simulation models and in vitro-in vivo pharmacokinetic correlation models (IVIVC) for the prediction of pharmacokinetic parameters. The pharmacokinetic simulation model is a tool that interprets drug kinetics in the living environment under specific conditions using computational and mathematical models. In addition, the IVIVC model are a fundamental part of the drug discovery process. Analyzing PK/PD predictions (i.e., pharmacokinetic/pharmacodynamic predictions) at the early stages of drug development is necessary for lead optimization strategies and also to further reduce attrition rates. There have been significant advancements in the development of new in-vitro and in-vivo strategies to improve and characterize pharmacokinetic properties. IVIVC models are being proposed as a cost-effective alternative to assess biopharmaceutical properties to analyze the bioavailability of drugs and determine their application. Hence, such in-vivo and in-vitro models are anticipated to provide lucrative opportunities for the pharmacokinetics services market in the near future.

Pharmacokinetics Services Market Share Analysis by Geography

The geographic scope of the pharmacokinetics services market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. In North America, the pharmacokinetics services market is currently in the growth phase and experiencing exponential growth. The US accounts for the largest share of the pharmacokinetics services market in North America. The country has emerged as a leading clinical research destination; it accounts for ~50% of the total clinical trials conducted in the world. The availability of established medical infrastructure, fast approval timelines, and favorable regulatory framework create a conducive environment for pharmaceutical research companies to conduct clinical trials. Moreover, the data generated in trials conducted in the US is accepted globally. As per a World Health Organization (WHO) report, the US registered the highest number of clinical trials (157,618) in 2021. The rising number of research studies and clinical trials in North American countries is expected to have a positive impact on the pharmacokinetics services market in this region.

Pharmacokinetics Services Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1,579.87 Million
Market Size by 2031 US$ 874.96 Million
Global CAGR (2023 - 2031) 7.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Type
  • Small Molecules
  • Large Molecules
  • Others
By Service Type
  • PK/PD Analysis and Reporting
  • Pre clinical ADME and Human Studies
  • Dosing Simulations
  • Risk Analysis
  • Others
By Therapeutic Application
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Respiratory Disorders
  • Neurological Disorders
  • Gynecological
  • Others
By End User
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Charles River Laboratories International Inc.,
  • Eurofins Scientific SE,
  • Evotec SE,
  • Certara Inc.,
  • Parexel International Corp,
  • Thermo Fisher Scientific Inc.,
  • Allucent,
  • PACIFIC BIOLABS,
  • SGS SA,
  • Shanghai Medicilon Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Pharmacokinetics Services Market News and Recent Developments

    The pharmacokinetics services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the pharmacokinetics services market are mentioned below:

    • Thermo Fisher Scientific expanded its clinical research operations with the opening of a state-of-the-art bioanalytical lab in Richmond, Virginia. The new unit will support the burgeoning demand generated in the biopharmaceutical ecosystem for consistent, high-quality laboratory services to accelerate drug development. The Richmond Bioanalytical Lab, whose entities have been operating since 1985, provides services for all phases of small molecule drug, biologics, vaccine, and biomarker development. Drug testing services include drug PK/PD, and immunogenicity and biomarker quantitation to support drug efficacy and safety. (Source: Thermo Fisher Scientific, Press Release, October 2022)
    • Charles River Laboratories International, Inc., partnered with Kibur Medical to offer exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies. Kibur’s microdevice technology can hold up to 20 different compounds for local administration, which allows it to dose therapies directly into disease tissue, allowing for investigative studies of early-stage compounds where pharmacokinetic properties are poorly understood. (Source: Charles River Laboratories International, Inc., Newsletter, February 2021)

    Pharmacokinetics Services Market Report Coverage and Deliverables

    The “Pharmacokinetics Services Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    • Pharmacokinetics services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Pharmacokinetics services market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Pharmacokinetics services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the pharmacokinetics services market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Which condition segment dominates the Pharmacokinetics Services market?

    The market, by condition, is categorized into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest Pharmacokinetics Services market share in 2023. It is further anticipated to register the highest CAGR during the forecast period.

    Which end user segment dominates the Pharmacokinetics Services market?

    The market, by end user, is categorized into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2023, Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.

    Which treatment type segment dominates the Pharmacokinetics Services market?

    By treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest Pharmacokinetics Services market share in 2023. Further, the microdermabrasion segment is anticipated to register the highest CAGR during the forecast period.

    What was the estimated Pharmacokinetics Services market size in 2023?

    The Pharmacokinetics Services market was valued at US$ 6,676.23 million in 2023.

    What are the growth estimates for the Pharmacokinetics Services market till 2030?

    The Pharmacokinetics Services market is expected to be valued at US$ 11,788.50 million in 2030.

    Who are the major players in the Pharmacokinetics Services market?

    The Pharmacokinetics Services market majorly consists of the players, including Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Certara Inc., Parexel International Corp, Thermo Fisher Scientific Inc., Allucent, PACIFIC BIOLABS, SGS SA, and Shanghai Medicilon Inc..

    What factors drive the Pharmacokinetics Services market?

    Factors such as the rising prevalence of chronic and infectious diseases, the expanding range of applications of pharmacokinetic studies, and the outsourcing of pharmacokinetics services to contract research organizations propel the market growth. However, the limited reach of pharmacokinetics service providers in emerging countries impedes the growth of the market.

    What is Pharmacokinetics Services?

    Pharmacokinetics is the study of how the body absorbs, distributes, metabolizes, and excretes drugs. It is a crucial aspect of drug development as it helps determine the dosage, timing, and route of administration of a drug to achieve the desired therapeutic effect. Pharmacokinetic services include Data Management, Programming, and CDISC Dataset Creation, Noncompartmental PK Analysis (NCA), Population Pharmacokinetics (popPK), Analysis Plans, Dosing Simulations, Comprehensive Submission-Ready Packages for Regulatory Authorities, Designing and Interpreting Nonclinical and Clinical ADME Studies, and Bioanalytical Method Validation, Reports, and Compendial Analytical Methods.

    The List of Companies - Pharmacokinetics Services Market 

    1. Charles River Laboratories International Inc.
    2. Eurofins Scientific SE
    3. Evotec SE
    4. Certara Inc.
    5. Parexel International Corp
    6. Thermo Fisher Scientific Inc.
    7. Allucent
    8. PACIFIC BIOLABS
    9. SGS SA
    10. Shanghai Medicilon Inc.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..